Drug Shortage Report for TEVA-ROSUVASTATIN

Last updated on 2023-04-28 History
Report ID 120250
Drug Identification Number 02354624
Brand name TEVA-ROSUVASTATIN
Common or Proper name ROSUVASTATIN 20MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ROSUVASTATIN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2020-07-13
Estimated end date Unknown
Actual end date 2023-04-27
Shortage status Resolved
Updated date 2023-04-28
Company comments Allocating 100% of Teva market for duration of risk period.
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-07-14 English Compare
v2 2020-07-14 French Compare
v3 2020-08-13 English Compare
v4 2020-08-13 French Compare
v5 2020-08-20 English Compare
v6 2020-08-20 English Compare
v7 2020-08-20 French Compare
v8 2020-09-22 English Compare
v9 2020-09-22 French Compare
v10 2021-01-07 English Compare
v11 2021-01-07 French Compare
v12 2021-01-14 English Compare
v13 2021-01-14 French Compare
v14 2021-03-04 English Compare
v15 2021-03-04 French Compare
v16 2021-03-25 English Compare
v17 2021-03-25 French Compare
v18 2021-04-01 English Compare
v19 2021-04-01 French Compare
v20 2021-05-06 English Compare

Showing 1 to 20 of 24